Ryo Mukai

Comparison of submacular hemorrhage incidences under aflibercept and faricimab treat-and-extend regimens in neovascular age-related macular degeneration

Abstract Background We aimed to compare the incidences of submacular hemorrhage (SMH) under two treat-and-extend regimens with aflibercept (IVA) and faricimab (IVFa) in patients with neovascular age-related macular degeneration (nAMD) and to perform exploratory analyses of age-st...